Rivaroxaban gets approval for use in patients with renal impairment

Rivaroxaban (Xarelto) is now approved in Australia for patients with severe renal impairment down to a creatinine clearance of 15 mL/min. The change brings the DOACs use in Australia into line with other countries including in Europe, the US and Canada. Associate...

Rivaroxaban (Xarelto) is now approved in Australia for patients with severe renal impairment down to a creatinine clearance of 15...

Infection

‘Do not use hydroxychloroquine’: National Taskforce strengthens its recommendation

Expert advice on the use of hydroxychloroquine in the treatment of COVID-19 has been strengthened from “not recommended” to “do not use”. The National COVID-19 Clinical Evidence Taskforce now makes a clear recommendation against the use of hydroxychloroquine for people with COVID-19...

Expert advice on the use of hydroxychloroquine in the treatment of COVID-19 has been strengthened from “not recommended” to “do...

Doctors health

PPE unmasked: why healthcare workers in Australia are inadequately protected against coronavirus

In Victoria, more than 1,100 health-care workers have now been infected with SARS-CoV-2, the coronavirus that causes COVID-19. Some 11% of active cases are workers in the health-care sector. Health-care workers are reported to be among those fighting for life in Victorian intensive care units. While...

In Victoria, more than 1,100 health-care workers have now been infected with SARS-CoV-2, the coronavirus that causes COVID-19. Some 11% of active...

Heart disease

Coronary calcium scores should guide statin treatment decisions

CT calcium scoring could be added to government-funded ‘Heart Health Checks’ to improve the targeting of statin treatment for primary prevention of cardiovascular disease, cardiologists say. A Victorian study has found that the current Australian absolute cardiovascular disease risk (ACVDR...

CT calcium scoring could be added to government-funded ‘Heart Health Checks’ to improve the targeting of statin treatment for primary...